Selective αv integrin depletion identifies a core, targetable molecular pathway that regulates fibrosis across solid organs

DSpace/Manakin Repository

Selective αv integrin depletion identifies a core, targetable molecular pathway that regulates fibrosis across solid organs

Citable link to this page

 

 
Title: Selective αv integrin depletion identifies a core, targetable molecular pathway that regulates fibrosis across solid organs
Author: Henderson, Neil C; Arnold, Thomas D; Katamura, Yoshio; Giacomini, Marilyn M; Rodriguez, Juan D; McCarty, Joseph H; Pellicoro, Antonella; Raschperger, Elisabeth; Betsholtz, Christer; Ruminski, Peter G; Griggs, David W; Prinsen, Michael J; Maher, Jacquelyn J; Iredale, John P; Lacy-Hulbert, Adam; Adams, Ralf H; Sheppard, Dean

Note: Order does not necessarily reflect citation order of authors.

Citation: Henderson, N. C., T. D. Arnold, Y. Katamura, M. M. Giacomini, J. D. Rodriguez, J. H. McCarty, A. Pellicoro, et al. 2013. “Selective αv integrin depletion identifies a core, targetable molecular pathway that regulates fibrosis across solid organs.” Nature medicine 19 (12): 10.1038/nm.3282. doi:10.1038/nm.3282. http://dx.doi.org/10.1038/nm.3282.
Full Text & Related Files:
Abstract: Myofibroblasts are the major source of extracellular matrix components that accumulate during tissue fibrosis, and hepatic stellate cells (HSCs) are the major source of myofibroblasts in the liver. To date, robust systems to genetically manipulate these cells have not existed. We report that Pdgfrb-Cre inactivates genes in murine HSCs with high efficiency. We used this system to delete the αv integrin subunit because of the suggested role of multiple αv integrins as central mediators of fibrosis in multiple organs. Depletion of the αv integrin subunit in HSCs protected mice from CCl4-induced hepatic fibrosis, whereas global loss of αvβ3, αvβ5 or αvβ6 or conditional loss of αvβ8 on HSCs did not. Pdgfrb-Cre effectively targeted myofibroblasts in multiple organs, and depletion of αv integrins using this system was also protective in models of pulmonary and renal fibrosis. Critically, pharmacological blockade of αv integrins by a novel small molecule (CWHM 12) attenuated both liver and lung fibrosis, even when administered after fibrosis was established. These data identify a core pathway that regulates fibrosis, and suggest that pharmacological targeting of all αv integrins may have clinical utility in the treatment of patients with a broad range of fibrotic diseases.
Published Version: doi:10.1038/nm.3282
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855865/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12406665
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters